Journal article 1569 views
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
C Mathieu,
P Hollander,
B Miranda-Palma,
J Cooper,
E Franek,
D Russell-Jones,
J Larsen,
S. C Tamer,
S. C Bain,
Steve Bain 
Journal of Clinical Endocrinology & Metabolism, Volume: 98, Issue: 3, Pages: 1154 - 1162
Swansea University Author:
Steve Bain
Full text not available from this repository: check for access using links below.
DOI (Published version): 10.1210/jc.2012-3249
Abstract
Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
| Published in: | Journal of Clinical Endocrinology & Metabolism |
|---|---|
| ISSN: | 0021-972X |
| Published: |
2013
|
| Online Access: |
Check full text
|
| URI: | https://cronfa.swan.ac.uk/Record/cronfa16198 |
| College: |
Faculty of Medicine, Health and Life Sciences |
|---|---|
| Issue: |
3 |
| Start Page: |
1154 |
| End Page: |
1162 |